All Insights
Showing 85 - 96 of 7750
Life Sciences and Healthcare
Medtech sector faces new EU 'green deal' recommendations
Greener medical devices and processes are among MedTech Europe's recommendations for business sustainability
The UK Budget
HR pensions spotlight: what do pensions changes in the UK Budget mean for employers?
Inheritance tax changes are much wider than expected
Real estate
Housebuilding market study: UK government responds to CMA proposals
Broad acceptance of recommendations to improve the housebuilding market confirmed by UK government, with detail awaited
Regulatory and compliance
Are you prepared for the forthcoming changes on prompt payment terms for public tendering in the UK?
Failure to comply with measures will mean companies cannot participate in central government procurements over £5 million
ESG – Environmental, Social and Governance
ESG Knowledge Update | November 2024
Welcome to our Osborne Clarke ESG Knowledge Update, which offers a round-up of legal, regulatory and market news
Employment and pensions
UK chancellor lays out 'fit for the future' vision for the Local Government Pension Scheme
How will the Mansion House announcements about LGPS 'megafunds' and asset pools affect administering authorities?
Decarbonisation
New climate finance – a steep climb up the COP29 hill?
Discussions continue on the next stage of climate financing, to replace previous annual goals set for contributing countries
Energy and Utilities
The Energy Transition | UK government confirms bonus scheme for offshore wind
Welcome to our top picks of the latest energy regulatory and market developments in the UK's transition to net zero
Life Sciences and Healthcare
Investment control in transactions in the life sciences and healthcare sector
Investment control means that additional regulatory approvals are required, affecting the timeline, complexity and costs of a transaction
Knowledge Notes
UK Knowledge Collection | Sustainability, In-house Lawyer Talks, and regulatory challenges in M&A
Welcome to this week's Knowledge Collection
Corporate
UK directors' duties: IOD issues guidance on the importance of sustainable business practice
New voluntary code of conduct provides helpful steer to directors – especially with regard to 'responsible business'
Life Sciences and Healthcare
Life sciences dealmakers need to anticipate sector-specific factors in European M&A
European regulatory and intellectual property complexities must be addressed when engaging in mergers and acquisitions
